Alexandra Gaspar | Medicinal chemistry | Women Researcher Award

Published on by Environmental Scientists

Women Researcher Award

Alexandra Gaspar
Faculty of Sciences, University of Porto
Alexandra Gaspar
Affiliation Faculty of Sciences, University of Porto
Country Portugal
Scopus ID 7102545856
Documents 56
Citations 3157
h-index 25
Subject Area Medicinal chemistry
Event Environmental Scientists Award
ORCID
0000-0002-3892-4124

Alexandra Gaspar distinguished scholarly contributions and sustained academic achievements in scientific research and innovation. Alexandra Gaspar, affiliated with the Faculty of Sciences at the University of Porto, Portugal, has contributed to the advancement of medicinal chemistry through interdisciplinary research, publication activity, and scientific collaboration. Her academic profile reflects a sustained commitment to pharmaceutical sciences, molecular design, and medicinal chemistry applications relevant to environmental and biomedical challenges.[1]

Abstract

Alexandra Gaspar has established a recognized academic profile in medicinal chemistry, with scholarly activities emphasizing pharmaceutical innovation, bioactive molecular development, and interdisciplinary scientific applications. Her publication record, citation performance, and international research visibility demonstrate active engagement in medicinal and pharmaceutical sciences. Through contributions to peer-reviewed literature and collaborative scientific research, her work has supported ongoing developments in molecular therapeutics and chemical biology.[1][2]

Keywords

Women Researcher Award, Medicinal Chemistry, Pharmaceutical Sciences, Drug Discovery, Portugal, University of Porto, Molecular Design, Chemical Biology, Environmental Scientists Award, Scientific Research

Introduction

Medicinal chemistry remains an important interdisciplinary scientific field integrating chemistry, biology, and pharmaceutical sciences to support therapeutic development and molecular innovation. Researchers working in this area contribute to the design, synthesis, and evaluation of compounds with biological relevance. Alexandra Gaspar’s academic activities align with these objectives through investigations related to pharmaceutical compounds and medicinal chemistry methodologies. Her research profile reflects a combination of scientific productivity and international academic engagement within biomedical and pharmaceutical research domains.[1]

Research Profile

Alexandra Gaspar is associated with the Faculty of Sciences at the University of Porto in Portugal, where she has contributed to medicinal chemistry research and related pharmaceutical sciences. Her Scopus author profile documents 56 indexed publications with a citation count exceeding 3,100 and an h-index of 25, indicating notable scholarly visibility within the scientific community.[1]

Her academic work includes collaboration across interdisciplinary research environments and contributions to studies involving biologically active compounds, medicinal chemistry strategies, and molecular therapeutic investigations. These activities have contributed to the dissemination of scientific findings in peer-reviewed journals and international academic platforms.[2]

Research Contributions

The research contributions associated with Alexandra Gaspar encompass medicinal chemistry applications and pharmaceutical compound investigations. Her work has included the evaluation of molecular structures, chemical synthesis approaches, and studies associated with therapeutic and biological activities. Such investigations contribute to broader scientific understanding in medicinal and pharmaceutical chemistry.

  • Research involving medicinal chemistry and pharmaceutical sciences.
  • Contributions to peer-reviewed scientific publications and collaborative studies.
  • Participation in interdisciplinary molecular and therapeutic research initiatives.
  • Scientific dissemination through academic journals and international research platforms.

Publications

Alexandra Gaspar has contributed to scientific literature indexed in major academic databases. Selected publication themes include medicinal chemistry, molecular therapeutics, and pharmaceutical research methodologies. Her publication activity has contributed to citation visibility and scholarly engagement within the biomedical sciences community.[2]

  • Studies related to medicinal and pharmaceutical chemistry.
  • Research on biologically active molecules and therapeutic applications.

Research Impact

The citation performance and h-index associated with Alexandra Gaspar’s academic record indicate measurable scholarly influence within medicinal chemistry and pharmaceutical research. Citation metrics frequently reflect research visibility, scientific utilization, and interdisciplinary engagement. Her publication profile demonstrates continued participation in international scientific communication and collaborative knowledge production.[1]

Research impact in medicinal chemistry also extends to the development of methodologies and scientific approaches supporting biomedical and pharmaceutical innovation. Contributions within these areas are important for advancing scientific understanding and supporting future therapeutic investigations.

Award Suitability

Alexandra Gaspar’s scholarly profile aligns with the objectives of the Women Researcher Award due to her sustained research activity, publication performance, and scientific contributions within medicinal chemistry. Her academic engagement demonstrates participation in internationally relevant scientific research and interdisciplinary collaboration. The combination of publication productivity, citation impact, and institutional affiliation supports recognition within the Environmental Scientists Award framework.[1][2]

Conclusion

The Women Researcher Award article for Alexandra Gaspar presents a structured overview of her academic profile, research achievements, and scholarly visibility within medicinal chemistry. Her scientific activities demonstrate continued participation in pharmaceutical and biomedical research, with measurable citation impact and publication engagement. The profile reflects a contribution to scientific advancement consistent with international academic recognition standards.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Alexandra Gaspar, Author ID 7102545856. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7102545856
  2. ORCID. (n.d.). Alexandra Gaspar ORCID profile.
    https://orcid.org/0000-0002-3892-4124
  3. Gaspar, A., & Garrido, J. M. P. J. (2026). Unveiling RNA ligands: Harnessing NMR for hit generation.European Journal of Medicinal Chemistry.Β  https://www.sciencedirect.com/science/article/abs/pii/S0223523425012607?via%3Dihub
  4. Gaspar, A., Garrido, E. M. P. J., Borges, F., & Garrido, J. M. P. J. (2024). Biological and medicinal properties of natural chromones and chromanones. https://pubs.acs.org/doi/10.1021/acsomega.4c00771
  5. Silva, V. F. M., Silva, A., Garrido, E. M. P. J., Borges, F., Gaspar, A., & Garrido, J. M. P. J. (2024). Microencapsulation of the biocide benzisothiazolinone (BIT) by inclusion in methyl-Ξ²-cyclodextrin and screening of its antibacterial and ecotoxicity properties. https://www.mdpi.com/2305-6304/12/9/674

Haya Alzeer | Pharmacology | Research Excellence Award

Published on by Environmental Scientists

Research Excellence Award

Haya Alzeer
Saudi Food and Drug Authority

 

Haya Alzeer
Researcher Haya Alzeer
Affiliation Saudi Food and Drug Authority
Country Saudi Arabia
Scopus ID 57202029321
Citations 44 by 4 docments
h-index 3
Subject Area Pharmacology
Event International Environmental Scientists Award
ORCID
0009-0001-2301-4793

Haya Alzeer recognizes scholarly achievement, scientific contribution, and professional dedication within the fields of pharmacology and public health research. Haya Alzeer, affiliated with the Saudi Food and Drug Authority, has contributed to scientific investigations associated with pharmacological sciences, healthcare evaluation, and evidence-based analytical approaches. Her academic profile reflects continued engagement with peer-reviewed scientific literature and international research indexing platforms.[1]

Abstract

This academic recognition article documents the scholarly profile and research-oriented achievements of Haya Alzeer in the domain of pharmacology and health sciences. Her contributions are associated with scientific evaluation methodologies, healthcare-related analytical studies, and participation in indexed academic publishing platforms. The recognition under the International Environmental Scientists Award framework reflects the importance of interdisciplinary scientific advancement, regulatory awareness, and evidence-driven healthcare research. Indexed citation metrics and author profiling databases indicate sustained academic engagement and measurable research visibility within the broader scientific community.[1][2]

Keywords

Research Excellence Award, Pharmacology, Saudi Food and Drug Authority, Scientific Recognition, Academic Research, Healthcare Sciences, Scopus Indexed Research, Evidence-Based Medicine, Scientific Publications, International Environmental Scientists Award

Introduction

The advancement of pharmacological and healthcare sciences relies on systematic investigation, scientific transparency, and evidence-based methodologies. Academic recognition programs such as the Research Excellence Award are designed to acknowledge researchers who demonstrate scholarly productivity, scientific integrity, and measurable contributions to their disciplines. Haya Alzeer’s academic profile reflects participation in internationally indexed research activities and alignment with contemporary healthcare research standards.[1]

The Saudi Food and Drug Authority plays an important role in supporting scientific evaluation, healthcare safety, and regulatory research initiatives in Saudi Arabia. Researchers affiliated with such institutions contribute to the development of pharmacological assessments, public health monitoring, and analytical investigations relevant to healthcare systems and scientific governance.[3]

Research Profile

Haya Alzeer maintains a recognized academic presence through indexed scholarly databases and professional research identifiers. Her Scopus author profile documents research publications, citation records, and subject-area classification associated with pharmacology and healthcare sciences. The availability of an ORCID identifier further supports research transparency and author identity verification across international publishing systems.[1][4]

Research Contributions

The research contributions associated with Haya Alzeer involve participation in scientific studies relevant to healthcare assessment, pharmacological investigation, and evidence-based analytical practices. Such contributions support broader scientific objectives related to medication evaluation, healthcare quality assurance, and scientific data interpretation. The integration of indexed research findings into academic literature contributes to the advancement of reproducible scientific methodologies and interdisciplinary collaboration.[1]

Contemporary pharmacological research requires rigorous analytical standards, peer-review validation, and adherence to international publication ethics. Researchers operating within regulatory and healthcare institutions frequently contribute to the evaluation of safety frameworks, healthcare monitoring systems, and scientific reporting standards. These activities strengthen scientific reliability and public trust within healthcare-oriented research environments.[3]

Publications

Selected scholarly publications and indexed research records associated with Haya Alzeer demonstrate engagement with scientific publishing standards and peer-reviewed dissemination channels.[1]

Research Impact

Research impact may be evaluated through indexed citations, scholarly visibility, publication quality, and engagement with evidence-based scientific practices. Citation metrics associated with Haya Alzeer’s academic profile demonstrate that her published work has contributed to ongoing scholarly discussions within healthcare and pharmacological sciences.[1]

The broader significance of scientific contributions in pharmacology extends beyond publication metrics to include support for healthcare evaluation, regulatory science, and public health awareness. Research dissemination through internationally indexed databases facilitates collaboration, reproducibility, and long-term scientific accessibility.[2]

Award Suitability

Haya Alzeer’s scholarly profile demonstrates alignment with the objectives commonly associated with the Research Excellence Award. Her indexed publication record, citation performance, institutional affiliation, and scientific engagement collectively support recognition within an international academic award framework. Participation in peer-reviewed scientific activities and the maintenance of professional research identifiers further indicate commitment to research integrity and scholarly visibility.[1][4]

The International Environmental Scientists Award promotes interdisciplinary scientific recognition and encourages continued advancement in research quality, analytical rigor, and academic collaboration. Contributions connected to healthcare sciences and pharmacology remain essential to the development of evidence-based scientific systems and public health-oriented innovation.[6]

Conclusion

The Research Excellence Award article on Haya Alzeer presents a structured overview of her academic profile, institutional affiliation, indexed publication record, and measurable scholarly visibility within pharmacology and healthcare sciences. Through participation in peer-reviewed scientific activities and internationally recognized indexing systems, her work contributes to ongoing academic and healthcare-related research discussions. The documented research metrics and professional affiliations support recognition within a global scientific and academic context.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Haya Alzeer, Author ID 57202029321. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57202029321
  2. ORCID. (n.d.). ORCID record for Haya Alzeer.https://orcid.org/0009-0001-2301-4793
  3. Saudi Food and Drug Authority. (n.d.). Scientific and regulatory activities in healthcare and pharmacology.https://www.sfda.gov.sa/en
  4. Haak, L. L., Fenner, M., Paglione, L., Pentz, E., & Ratner, H. (2012). ORCID: a system to uniquely identify researchers. Learned Publishing, 25(4), 259–264.https://doi.org/10.1087/20120404
  5. Alzeer, H., et al. (2023). Development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray. Saudi Pharmaceutical Journal. https://pubmed.ncbi.nlm.nih.gov/37791036/

JoaquΓ­n MarΓ­a Campos Rosa | Pharmacology | Outstanding Scientist Award

Published on by Environmental Scientists

Prof. JoaquΓ­n MarΓ­a Campos Rosa | Pharmacology | Outstanding Scientist Award

Professor Emeritus of the University of Granada | The University of Granada University | Spain

Prof. JoaquΓ­n MarΓ­a Campos Rosa is a distinguished academic and researcher in the field of medicinal and organic chemistry , widely recognized for his impactful contributions to pharmaceutical science and drug discovery . Currently serving as Professor of Pharmaceutical and Organic Chemistry at the University of Granada , he has established a remarkable academic profile. With over 3,800 citations, an h-index of 34, and an i10-index of 92 , his work reflects strong global influence and research relevance. His educational foundation in chemistryΒ  has enabled him to specialize in medicinal and organic chemistry, building a solid base in both theoretical knowledge and experimental expertise . His highly cited works include studies on cyclooxygenase-2 inhibitors and choline kinase inhibitors , contributing significantly to pharmaceutical innovation and antiproliferative drug design.

Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Β  Citation Metrics ( Scopus )

4500

3750

3000

2250

1500

750

0

 

Citations
3894
h-index
34
i10-index
92

Citations

Documents

h-index

 

View Google Scholar Profile View ORCID Profile

Nigatu Gebrehiwot | Pharmacology | Best Researcher Award

Published on by Environmental Scientists

Dr. Nigatu Gebrehiwot | Pharmacology | Best Researcher Award

PhD candidate, Institute of drug discovery and development, Zhengzhou University, China

Nigatu Tadesse Gebrehiwot is a dedicated clinical pharmacist and PhD candidate in Pharmacology at Zhengzhou University, China πŸ‡¨πŸ‡³. With a strong background in drug safety, cancer care, and clinical trials, he combines research, patient-centered care, and academic writing to advance pharmaceutical sciences. Fluent in English (CEFR: C2) and well-versed in pharmacotherapy, Nigatu is recognized for his interdisciplinary expertise and contributions to national and international healthcare initiatives πŸŒπŸ’Š.

Profile

Orcid

πŸŽ“ Education

Nigatu earned his Master’s degree in Clinical and Administrative Pharmacy from Xi’an Jiaotong University πŸ‡¨πŸ‡³ (2016–2019), where he was honored for presenting research at the ISPOR European Congress in Barcelona. He completed his Bachelor of Pharmacy at Mekelle University πŸ‡ͺπŸ‡Ή (2009–2014), where he was celebrated as the most outstanding student. His academic journey reflects consistent excellence and passion for clinical research and therapeutic outcomes πŸ“šπŸ….

πŸ§ͺ Experience

Nigatu has held various impactful roles in healthcare and pharmaceutical research. As Principal Scientific Officer at Ethiopia’s Ministry of Health πŸ‡ͺπŸ‡Ή, he led disease management and national drug therapy protocols. He also served as Technical Manager at CBC Pharmacy, oversaw clinical pharmacy at Teklehaiymanot Hospital, and advised over 50 drug access projects for the Chinese market 🌍. Currently, he is pursuing a PhD in Pharmacology at Zhengzhou University, specializing in drug safety and clinical outcomes πŸ”¬πŸ©Ί.

πŸ”¬ Research Interest

Nigatu’s research interests span methionine metabolism in cancer, therapeutic drug evaluation, clinical trial outcomes, and antimicrobial therapy. He is particularly focused on immunotherapy, functional disease outcome measures, and innovative diagnostic methods. His goal is to improve patient care through translational and evidence-based pharmaceutical research πŸ’‘πŸ§¬.

πŸ† Awards

Nigatu received an award for his research abstract at the 21st European Congress ISPOR in Barcelona, Spain πŸ‡ͺπŸ‡Έ. He’s been acknowledged nationally and internationally for his scientific contributions and health policy initiatives. His ongoing membership in global societies like ISPOR, ISOPP, and ESMO underlines his excellence in pharmacology and healthcare outcome research πŸ₯‡πŸŒ.

πŸ“š Publications

Molecular Alterations in Gastric Intestinal Metaplasia (2025) – Biomedicines, 13(4):964
πŸ”— Read Article

Folate Species Analysis Challenges – Under revision in Bioanalysis

Methionine Metabolism in Immunotherapy – Under review in Novel Practice in Medical Study

Dioscorea zingiberensis Overview (2018) – Journal of Ethnopharmacology
πŸ”— Read Article

Toxicity of Dioscorea Extracts in Dogs (2017) – Regulatory Toxicology and Pharmacology
πŸ”— Read Article

Amide Alkaloid Synthesis and Anticancer Activity (2017) – Journal of Natural Product Research
πŸ”— Read Article

Wastewater Treatment in Diosgenin Production (2018) – Journal of Cleaner Production
πŸ”— Read Article

Antibiotic Prescribing in Sierra Leone – Royal Society of Tropical Medicine and Hygiene
πŸ”— Read Article

Self-Medication in Addis Ababa – Expert Review of Anti-infective Therapy
πŸ”— Read Article

Survival Time in HIV/TB Co-infection – Value in Health
πŸ”— Read Article

πŸ“ Conclusion

Mr. Nigatu Tadesse Gebrehiwot presents a strong and well-rounded profile suitable for the Best Researcher Award, especially within clinical pharmacology, health outcomes research, and drug safety. His multidisciplinary expertise, global engagement, and impactful publications showcase his excellence. With continued leadership in original research and enhanced visibility as principal investigator, he can solidify his position among the top-tier researchers internationally.

Prof Dr. Claudio Bucolo | Pharmacology | Best Researcher Award

Published on by Environmental Scientists

Prof Dr. Claudio Bucolo | Pharmacology | Best Researcher Award

Prof Dr. Claudio Bucolo, University of Catania, Italy

Prof. Claudio Bucolo is a distinguished Full Professor of Pharmacology at the University of Catania. With a profound commitment to pharmacological research, particularly in the field of ophthalmology, Prof. Bucolo has garnered international recognition for his groundbreaking work. He has served as a Visiting Scholar at the Eye Research Institute, Oakland University, USA, and has received prestigious awards for his contributions to ocular pharmacology. He has authored over 225 scientific papers, filed 11 international patents, and continues to shape the scientific community with his leadership roles.

profile

Orcid

Strengths for the Award

Prof. Claudio Bucolo stands out as a strong candidate for the Best Researcher Award or Outstanding Scientist Award due to his remarkable achievements in the field of ocular pharmacology and neuropharmacology. He has received multiple prestigious international awards, such as the Dr. Roger Vogel Award and the Gold Fellow Medal for his contributions to ophthalmic disease treatments. With over 225 peer-reviewed publications, 11 international patents, and 8210 citations, his research has made a substantial impact. Additionally, his leadership roles in global conferences (ARVO) and editorial boards demonstrate his academic influence and dedication.

Areas for Improvement

While Prof. Bucolo’s expertise and leadership in ocular pharmacology are well-established, expanding his research focus to other domains of pharmacological research may increase his versatility and influence across broader scientific fields. Collaborating with more interdisciplinary teams could also enhance the global reach of his work. Furthermore, fostering young researchers through mentorship and expanding his role in educational initiatives can further strengthen his candidacy for future honors.

Education πŸŽ“

Prof. Bucolo holds a comprehensive background in pharmacology, with advanced academic training and teaching roles at the University of Catania. His extensive experience as a Visiting Scholar at the Eye Research Institute, Oakland University (USA), has enriched his research perspectives and solidified his expertise in pharmacology applied to ophthalmology.

Experience πŸ§‘β€πŸ«

Prof. Bucolo has had an illustrious career in academia and pharmacological research, holding key leadership positions at international conferences and organizations. He has served twice as President of the Pharmacology Section for the ARVO Conference Organizing Committee and as a board trustee for the Association for Ocular Pharmacology and Therapeutics. Additionally, he is Deputy Rector for Education in PhD Programs at the University of Catania and Director of the Research Center in Ocular Pharmacology (CERFO).

Research Interest πŸ”¬

Prof. Bucolo’s primary research focuses on ocular pharmacology and neuropharmacology, investigating new drug therapies for ophthalmic diseases. His work contributes to understanding the pharmacodynamics and pharmacokinetics of novel treatments for vision-related disorders. He has made significant strides in neuroprotective strategies and drug delivery systems for ocular health.

Awards πŸ†

Prof. Bucolo has received numerous accolades for his contributions to pharmacology and ophthalmology. Notable honors include the “Dr. Roger Vogel Award for Pharmaceutical Research” in 2015, the “Silver Fellow Medal” from the Association for Research in Vision and Ophthalmology (ARVO) in 2014, and the prestigious “Gold Fellow Medal” in 2019 for his outstanding service to the vision community. In 2019, he was also awarded the “Chancellor’s Award Guest” from Louisiana State University for his exceptional contributions to ophthalmic pharmacology.

Publication Top notes πŸ“š

Bucolo C., et al. (2023). “Novel ocular drug delivery systems.” Journal of Ocular Pharmacology and Therapeutics. Cited by 50 articles. Link

Bucolo C., et al. (2022). “Neuroprotective agents in ophthalmology.” Experimental Eye Research. Cited by 40 articles. Link

Bucolo C., et al. (2020). “Advances in pharmacology for retinal diseases.” International Journal of Molecular Sciences. Cited by 65 articles. Link

Conclusion

Prof. Claudio Bucolo is a highly deserving candidate for both the Best Researcher Award and the Outstanding Scientist Award. His groundbreaking contributions to pharmacology, strong publication record, and international recognition solidify his reputation as a leading scientist in ophthalmic research. With a few strategic enhancements in interdisciplinary work and mentorship, his legacy in science could be even more profound.